T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis

Immunology Letters

Volumn 157, Issue 1-2, 2014, Pages 38-44

  Zheng, Hui ^a,b   Zhang, Han ^a   Liu, Feng ^a   Qi, Yuanyuan ^a   Jiang, Hong ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Antigen presenting cell; Experimental autoimmune encephalomyelitis; Incomplete Freund's adjuvant; MOG

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD86 ANTIGEN; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE EXPRESSION; IMMUNIZATION; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFER; MALE; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

ANTIGEN-PRESENTING CELL; ANTIGEN-PRESENTING CELLS; APC; CENTRAL NERVOUS SYSTEM; CFA; CNS; COMPLETE FREUNDS ADJUVANT; COUNTS PER MINUTE; CPM; EAE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IFA; INCOMPLETE FREUND'S ADJUVANT; LIPOPOLYSACCHARIDE; LPS; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II; MEAN FLUORESCENCE INTENSITY; MFI; MHC-II; MOG; MS; MULTIPLE SCLEROSIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PBS; PHOSPHATE BUFFERED SALINE; SEM; STANDARD ERROR OF MEAN;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, SURFACE; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; IMMUNIZATION; LIPIDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MICE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 84889585717     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.11.001     Document Type: Article

References (26)

1. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
2. Murugesan N., Paul D., Lemire Y., Shrestha B., Ge S., Pachter J.S. Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus. Fluids Barriers CNS 2012, 9:15.
3. Liddi R., Beales P.E., Rosignoli G., Pozzilli P. Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse. Horm Metab Res 2000, 32:201-206.
4. Cannon G.W., Griffiths M.M., Woods M.L. Suppression of adjuvant-induced arthritis in DA rats by incomplete Freund's adjuvant. Arthritis Rheum 1993, 36:126-131.
5. Heeger P.S., Forsthuber T., Shive C., Biekert E., Genain C., Hofstetter H.H., et al. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J Immunol 2000, 164:5771-5781.
6. Fiori P., Ristori G., Cacciani A., Buttinelli C., Falcone M., Di Giovanni S., et al. Down-regulation of cell-surface CD4 co-receptor expression and modulation of experimental allergic encephalomyelitis. Int Immunol 1997, 9:541-545.
7. Wang R., Wang-Zhu Y., Gabaglia C.R., Kimachi K., Grey H.M. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope. J Exp Med 1999, 190:983-994.
8. Sun D., Wilson D.B., Cao L., Whitaker J.N. The role of regulatory T cells in Lewis rats resistant to EAE. J Neuroimmunol 1998, 81:177-183.
9. Fousteri G., Dave A., Bot A., Juntti T., Omid S., von Herrath M. Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ. Diabetologia 2010, 53:1958-1970.
10. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999, 162:3942-3949.
11. Lin M.S., Tse H.M., Delmastro M.M., Bertera S., Wong C.T., Lakomy R., et al. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res 2011, 50:213-220.
12. Pierson E., Simmons S.B., Castelli L., Goverman J.M. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev 2012, 248:205-215.
13. Almolda B., Gonzalez B., Castellano B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci 2011, 16:1157-1171.
14. Lanzavecchia A. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 1997, 185:1717-1719.
15. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-238.
16. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252.
17. El-behi M., Rostami A., Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2010, 5:189-197.
18. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 2011, 74:1-13.
19. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorovski T., et al. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J Exp Med 2003, 197:725-733.
20. Irony-Tur-Sinai M., Grigoriadis N., Lourbopoulos A., Pinto-Maaravi F., Abramsky O., Brenner T. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein. Exp Neurol 2006, 198:136-144.
21. Kel J., Oldenampsen J., Luca M., Drijfhout J.W., Koning F., Nagelkerken L. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol 2007, 170:272-280.
22. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., et al. CD40-CD40 Ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996, 93:2499-2504.
23. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996, 273:1864-1867.
24. +T cells in experimental autoimmune encephalomyelitis. J Autoimmun 2010, 35:33-44.
25. Wu Y., Zheng Z., Jiang Y., Chess L., Jiang H. The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 2009, 106:534-539.
26. Matsuda R., Kezuka T., Nishiyama C., Usui Y., Matsunaga Y., Okunuki Y., et al. Interleukin-10 gene-transfected mature dendritic cells suppress murine experimental autoimmune optic neuritis. Invest Ophthalmol Vis Sci 2012, 53:7235-7245.